Publications

Journal Articles

  1. Sundaram, V., Bloom, C., Zakeri, R., Halcox, J., Cohen, A., Bowrin, K., Briere, J., Banerjee, A., Simon, D., Cleland, J., Rajagopalan, S., & Quint, J. (n.d.) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015. European Heart Journal
  2. Harris, D., Lacey, A., Akbari, A., Torabi, F., Smith, D., Jenkins, G., Obaid, D., Chase, A., Gravenor, M., & Halcox, J. Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study. European Journal of Preventive Cardiology, 204748732091411
  3. James, M., Christian, D., Scott, S., Todd, C., Stratton, G., Demmler, J., McCoubrey, S., Halcox, J., Audrey, S., Ellins, L., & Brophy, S. Active Children Through Individual Vouchers Evaluation: A Mixed-Method RCT. American Journal of Preventive Medicine, 58(2), 232-243.
  4. Thayer, D., Rees, A., Kennedy, J., Collins, H., Harris, D., Halcox, J., Ruschetti, L., Noyce, R., Brooks, C., & Halcox, J. Measuring follow-up time in routinely-collected health datasets: Challenges and solutions. PLOS ONE, 15(2), e0228545
  5. Zonoozi, S., Ramsay, S., Papacosta, O., Lennon, L., Ellins, E., Halcox, J., Whincup, P., Wannamethee, S., & Ellins, L. Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine. Journal of Epidemiology and Community Health, jech-2018-211719
  6. Chiesa, S., Masi, S., Shipley, M., Ellins, L., Fraser, A., Hughes, A., Patel, R., Khir, A., Halcox, J., Singh-Manoux, A., Kivimaki, M., Celermajer, D., & Deanfield, J. Carotid artery wave intensity in mid- to late-life predicts cognitive decline: the Whitehall II study. European Heart Journal, 40(28), 2300-2309.
  7. Cegla, J., Neely, R., France, M., Ferns, G., Byrne, C., Halcox, J., Datta, D., Capps, N., Shoulders, C., Qureshi, N., Rees, A., Main, L., Cramb, R., Viljoen, A., Payne, J., & Soran, H. HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis, 291, 62-70.
  8. Harris, D., Thayer, D., Wang, T., Brooks, C., Murley, G., Gravenor, M., Hill, N., Lister, S., & Halcox, J. An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS). European Heart Journal - Cardiovascular Pharmacotherapy
  9. Harris, D., Lacey, A., Akbari, A., Obaid, D., Smith, D., Jenkins, G., Barry, J., Gravenor, M., & Halcox, J. Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort. Journal of the American Heart Association, 8(21), A74
  10. Harris, D., Lacey, A., Akbari, A., Obaid, D., Smith, D., Jenkins, G., Barry, J., Gravenor, M., & Halcox, J. Early Discontinuation of P2Y 12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort. Journal of the American Heart Association, 8(21)
  11. James, M., Christian, D., Scott, S., Todd, C., Stratton, G., Demmler, J., McCoubrey, S., Halcox, J., Audrey, S., Ellins, L., & Brophy, S. Predictors of cardiovascular health in teenagers (aged 13–14 years): a cross-sectional study linked with routine data. Open Heart, 6(2), e001147
  12. Ellins, L., Shipley, M., Rees, D., Kemp, A., Deanfield, J., Brunner, E., & Halcox, J. Associations of depression-anxiety and dyslipidaemia with subclinical carotid arterial disease: Findings from the Whitehall II Study. European Journal of Preventive Cardiology, 204748731987623
  13. James, M., Christian, D., Scott, S., Todd, C., Stratton, G., Demmler, J., McCoubrey, S., Halcox, J., Audrey, S., Ellins, E., Irvine, E., Brophy, S., & Ellins, L. What works best when implementing a physical activity intervention for teenagers? Reflections from the ACTIVE Project: a qualitative study. BMJ Open, 9(5), e025618
  14. Johns, I., Moschonas, K., Medina, J., Ossei-Gerning, N., Kassianos, G., & Halcox, J. Risk classification in primary prevention of CVD according to QRISK2 and JBS3 ‘heart age’, and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study. Open Heart, 5(2), e000849
  15. Borghi, C., Rodriguez-Artalejo, F., De Backer, G., Dallongeville, J., Medina, J., Nuevo, J., Guallar, E., Perk, J., Banegas, J., Tubach, F., Roy, C., & Halcox, J. Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study. International Journal of Cardiology, 253, 167-173.
  16. Cox, S., Ellins, E., Marealle, A., Newton, C., Soka, D., Sasi, P., Tanna, G., Johnson, W., Makani, J., Prentice, A., Halcox, J., Kirkham, F., & Ellins, L. Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial. The Lancet Haematology, 5(4), 147-160.
  17. James, M., Todd, C., Scott, S., Stratton, G., McCoubrey, S., Christian, D., Halcox, J., Audrey, S., Ellins, E., Anderson, S., Copp, I., Brophy, S., & Ellins, L. Teenage recommendations to improve physical activity for their age group: a qualitative study. BMC Public Health, 18(1)
  18. Franceschini, N., Giambartolomei, C., de Vries, P., Finan, C., Bis, J., Huntley, R., Lovering, R., Tajuddin, S., Winkler, T., Graff, M., Kavousi, M., Dale, C., Smith, A., Hofer, E., van Leeuwen, E., Nolte, I., Lu, L., Scholz, M., Sargurupremraj, M...., & O’Donnell, C. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes. Nature Communications, 9(1)
  19. Bannister, C., Halcox, J., Currie, C., Preece, A., & Spasić, I. A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease. PLOS ONE, 13(9), e0202685
  20. Ellins, E., Smith, K., Lennon, L., Papacosta, O., Wannamethee, S., Whincup, P., Halcox, J., & Ellins, L. Arterial pathophysiology and comparison of two devices for pulse wave velocity assessment in elderly men: the British regional heart study. Open Heart, 4(2), e000645
  21. Halcox, J., Wareham, K., Cardew, A., Gilmore, M., Barry, J., Phillips, C., & Gravenor, M. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation. Circulation, 136(19), 1784-1794.
    http://dx.doi.org/10.1161/circulationaha.117.030583
  22. Wannamethee, S., Welsh, P., Papacosta, O., Ellins, E., Halcox, J., Whincup, P., Sattar, N., & Ellins, L. Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis, 264, 36-43.
  23. Lacoin, L., Lumley, M., Ridha, E., Pereira, M., McDonald, L., Ramagopalan, S., Lefèvre, C., Evans, D., & Halcox, J. Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open, 7(9), e015363
  24. James, M., Christian, D., Scott, S., Todd, C., Stratton, G., McCoubrey, S., Halcox, J., Audrey, S., Ellins, E., Brophy, S., & Ellins, L. Active children through individual vouchers – evaluation (ACTIVE): protocol for a mixed method randomised control trial to increase physical activity levels in teenagers. BMC Public Health, 18(1)
  25. Halcox, J., Banegas, J., Roy, C., Dallongeville, J., De Backer, G., Guallar, E., Perk, J., Hajage, D., Henriksson, K., & Borghi, C. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovascular Disorders, 17(1)
  26. Zonoozi, S., Ramsay, S., Papacosta, O., Lennon, L., Ellins, E., Halcox, J., Whincup, P., Goya Wannamethee, S., & Ellins, L. Self-reported sleep duration and napping, cardiac risk factors and markers of subclinical vascular disease: cross-sectional study in older men. BMJ Open, 7(6), e016396
  27. Barnett, A., O'Hare, P., & Halcox, J. Guidelines for type 2 diabetes: keeping a finger on the pulse. The Lancet Diabetes & Endocrinology, 5(6), 420
  28. Freedman, B., Camm, J., Calkins, H., Healey, J., Rosenqvist, M., Wang, J., Albert, C., Anderson, C., Antoniou, S., Benjamin, E., Boriani, G., Brachmann, J., Brandes, A., Chao, T., Conen, D., Engdahl, J., Fauchier, L., Fitzmaurice, D., Friberg, L...., & Halcox, J. Screening for Atrial Fibrillation. Circulation, 135(19), 1851-1867.
  29. Ridker, P., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., Flather, M., Glynn, R., Gregoire, J., Jukema, J., Karpov, Y., Kastelein, J., Koenig, W., Lorenzatti, A., Manga, P., Masiukiewicz, U., Miller, M., Mosterd, A., Murin, J...., & Halcox, J. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. New England Journal of Medicine, 376(16), 1527-1539.
  30. Berni, E., de Voogd, H., Halcox, J., Butler, C., Bannister, C., Jenkins-Jones, S., Jones, B., Ouwens, M., & Currie, C. Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. BMJ Open, 7(1), e013398
  31. Ellins, E., New, K., Datta, D., Watkins, S., Haralambos, K., Rees, A., Rees, D., Halcox, J., Halcox, J., & Ellins, L. Validation of a new method for non-invasive assessment of vasomotor function. European Journal of Preventive Cardiology, 23(6), 577-583.
  32. Parsons, T., Sartini, C., Ellins, E., Halcox, J., Smith, K., Ash, S., Lennon, L., Wannamethee, S., Lee, I., Whincup, P., Jefferis, B., & Ellins, L. Objectively measured physical activity, sedentary time and subclinical vascular disease: Cross-sectional study in older British men. Preventive Medicine, 89, 194-199.
  33. Ellins, E., Rees, D., Deanfield, J., Steptoe, A., Halcox, J., & Ellins, L. Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?. Brain, Behavior, and Immunity
  34. Robson, R., Lacey, A., Luzio, S., Van Woerden, H., Heaven, M., Wani, M., Halcox, J., Castilla-Guerra, L., Dawson, J., Hewitt, J., Lacey, A., Luzio, S., & Halcox, J. HbA1cmeasurement and relationship to incident stroke. Diabetic Medicine, 33(4), 459-462.
  35. Borghi, C., Tubach, F., Backer, G., Dallongeville, J., Guallar, E., Medina, J., Perk, J., Roy, C., Banegas, J., Rodriguez-Artalejo, F., & Halcox, J. Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study. International Journal of Cardiology
  36. France, M., Rees, A., Datta, D., Thompson, G., Capps, N., Ferns, G., Ramaswami, U., Seed, M., Neely, D., Cramb, R., Shoulders, C., Barbir, M., Pottle, A., Eatough, R., Martin, S., Bayly, G., Simpson, B., Halcox, J., Edwards, R...., & Soran, H. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis
  37. Borghi, C., Rodriguez-Artalejo, F., De Backer, G., Dallongeville, J., Medina, J., Guallar, E., Perk, J., Banegas, J., Tubach, F., Roy, C., & Halcox, J. The association between blood pressure and lipid levels in Europe. Journal of Hypertension, 34(11), 2155-2163.
  38. Parsons, T., Sartini, C., Halcox, J., Smith, K., Ash, S., Lennon, L., Wannamethee, S., Lee, I., Whincup, P., Jefferis, B., & Ellins, L. Objectively measured physical activity and sedentary behaviour and ankle brachial index: Cross-sectional and longitudinal associations in older men. Atherosclerosis, 247, 28-34.
  39. Halcox, J., Misra, A., & Halcox, J. Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?. Metabolic Syndrome and Related Disorders, 13(1), 1-21.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84921501320&partnerID=MN8TOARS
  40. Halcox, J., Tubach, F., Sazova, O., Sweet, S., Medina, J., & Halcox, J. Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm. European Journal of Preventive Cardiology, 22(2), 200-202.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84920998304&partnerID=MN8TOARS
  41. Delmas, D., Halcox, J., Tubach, F., Lopez-Garcia, E., De Backer, G., Borghi, C., Dallongeville, J., Guallar, E., Medina, J., Perk, J., Sazova, O., Sweet, S., Roy, C., Banegas, J., & Rodriguez-Artalejo, F. Low Rates of Both Lipid-Lowering Therapy Use and Achievement of Low-Density Lipoprotein Cholesterol Targets in Individuals at High-Risk for Cardiovascular Disease across Europe. PLOS ONE, 10(2), e0115270
    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115270
  42. Radke, P., Halvorsen, S., Jukema, J., Kolh, P., Annemans, L., Postma, M., Ardissino, D., Kristensen, S., Bassand, J., Collet, J., Morais, J., Tuñón, J., Halcox, J., & Halcox, J. Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care, 16(2), 41-48.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84899883477&partnerID=MN8TOARS
  43. Halcox, J., Currie, C., & Halcox, J. Lipid-lowering therapy and mortality post-MI: is it just about the LDL?. Heart, 100(11), 825-826.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84900300213&partnerID=MN8TOARS
  44. Prescott, E., Abildstrøm, S., Aziz, A., Merz, N., Gustafsson, I., Halcox, J., Hansen, H., Hansen, P., Kastrup, J., Michelsen, M., Mygind, N., Ong, P., Pena, A., Rosengren, A., Sechtem, U., Søgaard, P., & Halcox, J. Improving diagnosis and treatment of women with angina pectoris and microvascular disease: The iPOWER study design and rationale. American Heart Journal, 167(4), 452-458.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84897057580&partnerID=MN8TOARS
  45. Edwards, M., Watkins, W., Kotecha, S., Halcox, J., Dunstan, F., Henderson, A., Kotecha, S., & Halcox, J. Higher systolic blood pressure with normal vascular function measurements in preterm-born children. Acta Paediatrica, 103(9), 904-912.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84906936365&partnerID=MN8TOARS
  46. Bhatti, Z., Finlay, A., Bolton, C., George, L., Halcox, J., Jones, S., Ketchell, R., Moore, R., Salek, M., & Halcox, J. Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine. Journal of the European Academy of Dermatology and Venereology, 28(10), 1344-1355.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84908102577&partnerID=MN8TOARS
  47. Bannister, C., Holden, S., Jenkins-Jones, S., Morgan, C., Halcox, J., Schernthaner, G., Mukherjee, J., Currie, C., & Halcox, J. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, Obesity and Metabolism, 16(11), 1165-1173.
    http://onlinelibrary.wiley.com/doi/10.1111/dom.12354/abstract
  48. Rees, E., Coulson, R., Dunstan, F., Evans, W., Blundell, H., Luzio, S., Dunseath, G., Halcox, J., Fraser, A., Rees, D., Dunseath, G., Luzio, S., & Halcox, J. Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk. Human Reproduction, 29(9), 2041-2049.
  49. Halcox, J., Roy, C., Tubach, F., Banegas, J., Dallongeville, J., De Backer, G., Guallar, E., Sazova, O., Medina, J., Perk, J., Steg, P., Rodríguez-Artalejo, F., Borghi, C., & Halcox, J. C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovascular Disorders, 14(1), 25
    http://bmccardiovascdisord.biomedcentral.com/articles/10.1186/1471-2261-14-25
  50. Ingram, T., Fraser, A., Bleasdale, R., Ellins, E., Margulescu, A., Halcox, J., James, P., & Ellins, L. Low-Dose Sodium Nitrite Attenuates Myocardial Ischemia and Vascular Ischemia-Reperfusion Injury in Human Models. Journal of the American College of Cardiology, 61(25), 2534-2541.
  51. Bhatti, Z., Salek, S., Bolton, C., George, L., Halcox, J., Jones, S., Ketchell, I., Moore, R., Sabit, R., Piguet, V., Finlay, A., & Halcox, J. The development and validation of the major life changing decision profile (MLCDP). Health and Quality of Life Outcomes, 11(1), 78
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84879865876&partnerID=MN8TOARS
  52. Poole, C., Halcox, J., Jenkins-Jones, S., Carr, E., Schifflers, M., Ray, K., Currie, C., & Halcox, J. Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort Study. Clinical Therapeutics, 35(1), 40-51.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84872416659&partnerID=MN8TOARS
  53. Halcox, J. & Halcox, J. Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters. Clinical Lipidology, 8(3), 329-344.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84878738742&partnerID=MN8TOARS
  54. Fabbri-Arrigoni, F., Clarke, L., Wang, G., Charakida, M., Ellins, E., Halliday, N., Brogan, P., Deanfield, J., Halcox, J., Klein, N., & Ellins, L. Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia. Pediatric Research, 72(3), 299-304.
  55. Dallongeville, J., Banegas, J., Tubach, F., Guallar, E., Borghi, C., Backer, G., Halcox, J., Massó-González, E., Perk, J., Sazova, O., Steg, P., Artalejo, F., & Halcox, J. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. European Journal of Preventive Cardiology, 19(3), 541-550.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84865565176&partnerID=MN8TOARS
  56. Begg, A., Connolly, S., Halcox, J., Kaba, A., Main, L., Ray, K., Purcell, H., Williams, H., Yellon, D., & Halcox, J. Omega-3 fatty acids in cardiovascular disease: re-assessing the evidence. British Journal of Cardiology, 19(2)
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84861663296&partnerID=MN8TOARS
  57. Ellins, E., Halcox, J., & Ellins, L. Where Are We Heading with Noninvasive Clinical Vascular Physiology? Why and How Should We Assess Endothelial Function?. Cardiology Research and Practice, 2011, 1-9.
  58. Halcox, J. Achievement of lipoprotein goals among patients with metabolic syndrome at high. Int Journal of Cardiology, 116, 210-214.
  59. Reiner, Ž., Catapano, A., De Backer, G., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P., Riccardi, G., Storey, R., Wood, D., & Halcox, J. Wytyczne ESC/EAS dotycza̧ce postêpowania w dyslipidemiach. Kardiologia Polska, 69
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84856080189&partnerID=MN8TOARS
  60. Halcox, J. & Halcox, J. The British Journal of Cardiology: Foreword. British Journal of Cardiology, 18
    http://www.scopus.com/inward/record.url?eid=2-s2.0-80053211482&partnerID=MN8TOARS
  61. Zafari, A., Quyyumi, A., Halcox, J., Rajagopalan, S., & Halcox, J. The Arterial Pulse: Vascular Biology, Vascular Function Testing, and Therapies. Cardiology Research and Practice, 1, 1-2.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-81555220887&partnerID=MN8TOARS
  62. Ryabikov, A., Malyutina, S., Halcox, J., Nikitin, Y., Marmot, M., Bobak, M., & Halcox, J. Prevalence and Predictors of Carotid Wall Triple Line Pattern in a General Population Sample. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(7), 1682-1688.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-79959692332&partnerID=MN8TOARS
  63. Halcox, J., Lindsay, S., Begg, A., Griffith, K., Mead, A., Barr, B., & Halcox, J. Lifestyle advice and drug therapy post-myocardial infarction: A survey of UK current practice. British Journal of Cardiology, 18
    http://www.scopus.com/inward/record.url?eid=2-s2.0-80053185125&partnerID=MN8TOARS
  64. Halcox, J. & Halcox, J. Letter by Halcox Regarding Article, "OMEGA, A Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction". Circulation, 124(1), e21-e21.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-79960343362&partnerID=MN8TOARS
  65. Godfrey, E., Halcox, J., & Halcox, J. How do we approach low high-density lipoprotein cholesterol in 2011?. European Cardiology, 7
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84856116056&partnerID=MN8TOARS
  66. Arrigoni, F., Matarin, M., Thompson, P., Michaelides, M., McClements, M., Redmond, E., Clarke, L., Ellins, E., Mohamed, S., Pavord, I., Hunt, D., Moore, A., Halcox, J., Sisodiya, S., & Halcox, J. Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy. European Journal of Human Genetics, 19(2), 131-137.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-78651387937&partnerID=MN8TOARS
  67. Guallar, E., Banegas, J., Blasco-Colmenares, E., Jiménez, F., Dallongeville, J., Halcox, J., Borghi, C., Massá-González, E., Tafalla, M., Perk, J., De Backer, G., Steg, P., Rodríguez-Artalejo, F., & Halcox, J. Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. BMC Public Health, 11(1), 704
    http://www.scopus.com/inward/record.url?eid=2-s2.0-80052860267&partnerID=MN8TOARS
  68. Reiner, Z., Catapano, A., De Backer, G., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P., Riccardi, G., Storey, R., Wood, D., & Halcox, J. ESC/EAS Kilavuzlari: Dislipidemilerin tedavisi. Turk Kardiyoloji Dernegi Arsivi, 39
    http://www.scopus.com/inward/record.url?eid=2-s2.0-84862880640&partnerID=MN8TOARS
  69. Catapano, A., Reiner, T., De Backer, G., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R., Wood, D., & Halcox, J. ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis, 217(1), 3-46.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-79960205374&partnerID=MN8TOARS
  70. Catapano, A., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Perrone Filardi, P., Riccardi, G., Storey, R., Wood, D., & Halcox, J. ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis, 217, 1-44.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-79959779582&partnerID=MN8TOARS
  71. Arrigoni, F., Matarin, M., Thompson, P., Michaelides, M., McClements, M., Redmond, E., Clarke, L., Ellins, E., Mohamed, S., Pavord, I., Klein, N., Hunt, D., Moore, A., Halcox, J., Sisodiya, S., Halcox, J., & Ellins, L. Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy. European Journal of Human Genetics, 19(9), 1018-1018.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-80051965468&partnerID=MN8TOARS
  72. Bundhoo, S., Anderson, R., Sagan, E., Dada, J., Harris, R., Halcox, J., Lang, D., James, P., & Halcox, J. Direct Vasoactive Properties of Thienopyridine-Derived Nitrosothiols. Journal of Cardiovascular Pharmacology, 58(5), 550-558.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-80955163799&partnerID=MN8TOARS
  73. Lee, W., Datta, B., Ong, B., Rees, A., Halcox, J., & Halcox, J. Defining the Role of Lipoprotein Apheresis in the Management of Familial Hypercholesterolemia. American Journal Cardiovascular Drugs, 11(6), 363-370.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-83055178362&partnerID=MN8TOARS
  74. Halcox, J. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. European Heart Journal, 32, 2143-2152.
  75. Halcox, J. & Halcox, J. What are omega-3 fatty acids and what is their role in cardiovascular health?. Primary Care Cardiovascular Journal, 3
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77957732281&partnerID=MN8TOARS
  76. Corr, U., Carré, F., Heuschmann, P., Hoffmann, U., Verschuren, M., Halcox, J., Giannuzzi, P., Saner, H., Wood, D., Piepoli, M., Benzer, W., Bjarnason-Wehrens, B., Dendale, P., Gaita, D., McGee, H., Mendes, M., Niebauer, J., Zwisler, A., Schmid, J., & Halcox, J. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. European Heart Journal, 31(16), 1967-1974.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77955933403&partnerID=MN8TOARS
  77. Rodríguez-Artalejo, F., Guallar, E., Borghi, C., Dallongeville, J., De Backer, G., Halcox, J., Hernndez-Vecino, R., Jiménez, F., Massá-Gonzlez, E., Perk, J., Steg, P., Banegas, J., & Halcox, J. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health, 10(1), 382
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77954962237&partnerID=MN8TOARS
  78. Lindsay, A., Halcox, J., & Halcox, J. Niacin Compared with Ezetimibe. New England Journal of Medicine, 362(11), 1046-1048.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77949603647&partnerID=MN8TOARS
  79. Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., James, S., Knuuti, J., Lopez-Sendon, J., Marco, J., Menicanti, L., Ostojic, M., Piepoli, M., Pirlet, C., Pomar, J., Reifart, N., Ribichini, F...., & Halcox, J. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 31(20), 2501-2555.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77958128969&partnerID=MN8TOARS
  80. Charakida, M., Donald, A., Leary, S., Halcox, J., Turner, M., Johnson, M., Loukogeorgakis, S., Okorie, M., Smith, G., Deanfield, J., Klein, N., & Halcox, J. Endothelial response to childhood infection: The role of mannose-binding lectin (MBL). Atherosclerosis, 208(1), 217-221.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-73449097770&partnerID=MN8TOARS
  81. Halcox, J. Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal. EHJ, 33, 1502-1510.
  82. Freeman, P., Halcox, J., & Halcox, J. Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction. Heart, 95(16), 1301-1302.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-68149155562&partnerID=MN8TOARS
  83. Charakida, M., Loukogeorgakis, S., Okorie, M., Masi, S., Halcox, J., Deanfield, J., Klein, N., & Halcox, J. Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy. Antiviral Therapy, 14(8), 1075-1079.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-77949316647&partnerID=MN8TOARS
  84. Weston, C., Weston, C., & Halcox, J. The author's reply:. Heart, 95(24), 2029-2029.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-71749097468&partnerID=MN8TOARS
  85. Halcox, J. & Ellins, L. Endothelial Function Predicts Progression of Carotid Intima-Media Thickness. Circulation, 119, 1005-1012.
  86. Ellins, E., Shamaei-Tousi, A., Steptoe, A., Donald, A., OʼMeagher, S., Halcox, J., Henderson, B., & Ellins, L. The relationship between carotid stiffness and circulating levels of heat shock protein 60 in middle-aged men and women. Journal of Hypertension, 26(12), 2389-2392.
  87. Agrawal, V., Ellins, E., Donald, A., Minhas, S., Halcox, J., Ralph, D., & Ellins, L. ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Systemic Vascular Endothelial Dysfunction in Peyronie's Disease. The Journal of Sexual Medicine, 5(11), 2688-2693.
  88. Ellins, E., Halcox, J., Donald, A., Field, B., Brydon, L., Deanfield, J., Steptoe, A., & Ellins, L. Arterial stiffness and inflammatory response to psychophysiological stress. Brain, Behavior, and Immunity, 22(6), 941-948.
  89. Halcox, J. Methodological Approaches to Optimize Reproducibility and Power in Clinical Studies of Flow-Mediated Dilation. JACC, 50(21), 1959-1964.
  90. Singh-Manoux, A., Britton, A., Kivimaki, M., Guéguen, A., Halcox, J., Marmot, M., & Halcox, J. Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: Evidence from the Whitehall II study. Atherosclerosis, 197(2), 541-548.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-41249102939&partnerID=MN8TOARS
  91. Clarke, L., Shah, V., Arrigoni, F., Eleftheriou, D., Hong, Y., Halcox, J., Klein, N., Brogan, P., & Halcox, J. Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction. Journal of Thrombosis and Haemostasis, 6(6), 1025-1032.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-43749105130&partnerID=MN8TOARS
  92. Taylor, J., Halcox, J., & Halcox, J. PDE5 inhibitors and pulmonary hypertension. Current Sexual Health Reports, 5(4), 171-178.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-60149086813&partnerID=MN8TOARS
  93. Chen, S., Donald, A., Storry, C., Halcox, J., Bonhoeffer, P., Deanfield, J., & Halcox, J. Impact of aortic stenting on peripheral vascular function and daytime systolic blood pressure in adult coarctation. Heart, 94(7), 919-924.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-46249133779&partnerID=MN8TOARS
  94. Kivimáki, M., Lawlor, D., Smith, G., Kumari, M., Donald, A., Britton, A., Casas, J., Shah, T., Brunner, E., Timpson, N., Halcox, J., Miller, M., Humphries, S., Deanfield, J., Marmot, M., Hingorani, A., & Halcox, J. Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study. PLoS ONE, 3(8), e3013
    http://www.scopus.com/inward/record.url?eid=2-s2.0-51549111362&partnerID=MN8TOARS
  95. Halcox, J. & Halcox, J. Dilatation in the femoral vascular bed does not cause retrograde relaxation of the iliac artery in the anaesthetized pig. Acta Physiologica, 194(3), 175-175.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-53549091298&partnerID=MN8TOARS
  96. Halcox, J. & Ellins, L. Endothelial dysfunction and Cytomegalovirus. Circulation, 117, 2657-2661.
  97. Shamaei-Tousi, A., Halcox, J., Henderson, B., & Halcox, J. Stressing the obvious? Cell stress and cell stress proteins in cardiovascular disease. Cardiovascular Research, 74(1), 19-28.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33847657433&partnerID=MN8TOARS
  98. Deanfield, J., Halcox, J., Rabelink, T., & Halcox, J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 115
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33947716172&partnerID=MN8TOARS
  99. Halcox, J., Nour, K., Zalos, G., Quyyumi, A., & Halcox, J. Endogenous Endothelin in Human Coronary Vascular Function: Differential Contribution of Endothelin Receptor Types A and B. Hypertension, 49(5), 1134-1141.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-34247880262&partnerID=MN8TOARS
  100. Charakida, M., Deanfield, J., Halcox, J., & Halcox, J. Childhood origins of arterial disease. Current Opinion in Pediatrics, 19(5), 538-545.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-34748906593&partnerID=MN8TOARS
  101. Ostberg, J., Storry, C., Donald, A., Attar, M., Halcox, J., Conway, G., & Halcox, J. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clinical Endocrinology, 66(0), 070302041622001-???.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33947201292&partnerID=MN8TOARS
  102. Charakida, M., Deanfield, J., Halcox, J., & Halcox, J. The role of nitric oxide in early atherosclerosis. European Journal of Clinical Pharmacology, 62(S1), 69-78.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33344474972&partnerID=MN8TOARS
  103. Bastiaenen, R., Halcox, J., & Halcox, J. The imaging of coronary artery disease. Medicine, 34(9), 373-376.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33845372750&partnerID=MN8TOARS
  104. Donald, A., Charakida, M., Cole, T., Friberg, P., Chowienczyk, P., Millasseau, S., Deanfield, J., Halcox, J., & Halcox, J. Non-Invasive Assessment of Endothelial Function. Journal of the American College of Cardiology, 48(9), 1846-1850.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33750463408&partnerID=MN8TOARS
  105. Page, S., Halcox, J., & Halcox, J. Management of hypertension. Medicine, 34(8), 290-295.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33845449570&partnerID=MN8TOARS
  106. Ostberg, J., Donald, A., Halcox, J., Storry, C., McCarthy, C., Conway, G., & Halcox, J. Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction. The Journal of Clinical Endocrinology & Metabolism, 90(9), 5161-5166.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-24344437175&partnerID=MN8TOARS
  107. Lindsay, A., Halcox, J., & Halcox, J. Stem cells as future therapy in cardiology. Hospital Medicine, 66
    http://www.scopus.com/inward/record.url?eid=2-s2.0-18244398945&partnerID=MN8TOARS
  108. Brunner, H., Cockcroft, J., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., Kiowski, W., Lüscher, T., Mancia, G., Natali, A., Oliver, J., Pessina, A., Rizzoni, D., Rossi, G., Salvetti, A., Spieker, L., Taddei, S., Webb, D., & Halcox, J. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*. Journal of Hypertension, 23(2), 233-246.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-20044373069&partnerID=MN8TOARS
  109. Deanfield, J., Donald, A., Ferri, C., Giannattasio, C., Halcox, J., Halligan, S., Lerman, A., Mancia, G., Oliver, J., Pessina, A., Rizzoni, D., Rossi, G., Salvetti, A., Schiffrin, E., Taddei, S., Webb, D., & Halcox, J. Endothelial function and dysfunction. Part I. Journal of Hypertension, 23(1), 7-17.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-19944430327&partnerID=MN8TOARS
  110. Charakida, M., Donald, A., Terese, M., Leary, S., Halcox, J., Ness, A., Smith, G., Golding, J., Friberg, P., Klein, N., Deanfield, J., & Halcox, J. Endothelial Dysfunction in Childhood Infection. Circulation, 111(13), 1660-1665.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-20244383151&partnerID=MN8TOARS
  111. Charakida, M., Donald, A., Green, H., Storry, C., Clapson, M., Caslake, M., Dunn, D., Halcox, J., Gibb, D., Klein, N., Deanfield, J., & Halcox, J. Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy. Circulation, 112(1), 103-109.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-21844475888&partnerID=MN8TOARS
  112. Halcox, J., Deanfield, J., Shamaei-Tousi, A., Henderson, B., Steptoe, A., Coates, A., Singhal, A., Lucas, A., & Halcox, J. Circulating human heat shock protein 60 in the blood of healthy teenagers: a novel determinant of endothelial dysfunction and early vascular injury?. Arteriosclerosis, thrombosis, and vascular biology., 25
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33644789221&partnerID=MN8TOARS
  113. Halcox, J., Deanfield, J., & Halcox, J. Childhood origins of endothelial dysfunction. Heart, 91(10), 1272-1274.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-25144520994&partnerID=MN8TOARS
  114. Halcox, J., Deanfield, J., & Halcox, J. Endothelial cell function testing: how does the method help us in evaluating vascular status?. Acta Paediatrica, 93(0), 48-54.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-10844261733&partnerID=MN8TOARS
  115. Halcox, J., Deanfield, J., & Halcox, J. Beyond the laboratory: Clinical implications for statin pleiotropy. Circulation, 109
    http://www.scopus.com/inward/record.url?eid=2-s2.0-2642559507&partnerID=MN8TOARS
  116. Ostberg, J., Brookes, J., McCarthy, C., Halcox, J., Conway, G., & Halcox, J. A Comparison of Echocardiography and Magnetic Resonance Imaging in Cardiovascular Screening of Adults with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism, 89(12), 5966-5971.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-10344221561&partnerID=MN8TOARS
  117. Zhu, J., Quyyumi, A., Wu, H., Csako, G., Rott, D., Zalles-Ganley, A., Ogunmakinwa, J., Halcox, J., Epstein, S., & Halcox, J. Increased Serum Levels of Heat Shock Protein 70 Are Associated With Low Risk of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(6), 1055-1059.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0038797792&partnerID=MN8TOARS
  118. Hill, J., Zalos, G., Halcox, J., Schenke, W., Waclawiw, M., Quyyumi, A., Finkel, T., & Halcox, J. Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. New England Journal of Medicine, 348(7), 593-600.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0037434561&partnerID=MN8TOARS
  119. Halcox, J., Nour, K., Zalos, G., Mincemoyer, R., Waclawiw, M., Rivera, C., Willie, G., Ellahham, S., Quyyumi, A., & Halcox, J. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. Journal of the American College of Cardiology, 40(7), 1232-1240.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0037009979&partnerID=MN8TOARS
  120. Halcox, J., Schenke, W., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M., Nour, K., Quyyumi, A., & Halcox, J. Prognostic Value of Coronary Vascular Endothelial Dysfunction. Circulation, 106(6), 653-658.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0037031266&partnerID=MN8TOARS
  121. Prasad, A., Zhu, J., Halcox, J., Waclawiw, M., Epstein, S., Quyyumi, A., & Halcox, J. Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction. Circulation, 106(2), 184-190.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0037047075&partnerID=MN8TOARS
  122. Halcox, J., Nour, K., Zalos, G., Quyyumi, A., & Halcox, J. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ETA receptor blockade. Circulation Research, 89
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0035941416&partnerID=MN8TOARS
  123. Halcox, J., Quyyumi, A., & Halcox, J. Coronary vascular endothelial function and myocardial ischemia: why should we worry about endothelial dysfunction?. Coronary Artery Disease, 12(6), 475-484.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0034759815&partnerID=MN8TOARS
  124. Halcox, J., Narayanan, S., Cramer-Joyce, L., Mincemoyer, R., Quyyumi, A., & Halcox, J. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. American Journal of Physiology - Heart and Circulatory Physiology, 280
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0034989338&partnerID=MN8TOARS
  125. McDermott, D., Halcox, J., Schenke, W., Waclawiw, M., Merrell, M., Epstein, N., Quyyumi, A., Murphy, P., & Halcox, J. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circulation Research, 89
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0035980162&partnerID=MN8TOARS
  126. Zhu, J., Quyyumi, A., Rott, D., Csako, G., Wu, H., Halcox, J., Epstein, S., & Halcox, J. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: Evidence for an autoimmune component of atherogenesis. Circulation, 103
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0035957031&partnerID=MN8TOARS
  127. Prasad, A., Halcox, J., Waclawiw, M., Quyyumi, A., & Halcox, J. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis. Journal of the American College of Cardiology, 38(4), 1089-1095.
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0034806542&partnerID=MN8TOARS
  128. Halcox, J., Sharma, A., Zalos, G., Panza, J., Quyyumi, A., & Halcox, J. Acute endothelin type a receptor antagonism improves human coronary vascular function. Heart, 83
    http://www.scopus.com/inward/record.url?eid=2-s2.0-33750908902&partnerID=MN8TOARS
  129. Halcox, J. & Halcox, J. Non-surgical chop cures right ventricular outflow obstruction. Heart, 81
    http://www.scopus.com/inward/record.url?eid=2-s2.0-0032920681&partnerID=MN8TOARS

Books

  1. Charakida, M., Halcox, J., Loukogeorgakis, S., Deanfield, J., & Halcox, J. Paediatric Cardiology

Conference Contributions

  1. Torabi, F., Lacey, A., Akbari, A., Harris, D., Lyons, R., Halcox, J., & Gravenor, M. Machine learning approaches in for prediction of 1-year risk of major bleeding events in anticoagulated atrial fibrillation patients with atrial fibrillation in Wales.. In ESC Heart & Stroke 2020
    https://escheart-stroke2020.org/programme/